Current Trends in Renal Surgery and Observation for Small Renal Masses

Drangsholt, Siri; Huang, William C.

doi:10.1016/j.ucl.2016.12.003

Cited by 16 publications

(20 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[10] The grade assigned to kidney tumors provides information about the aggressiveness of the tumor and is an important determining factor for the treatment selection and potential survival. [11] The likelihood of malignancy has been shown to increase proportionally with the size of the mass.…”

mentioning

confidence: 99%

“…Renal biopsy is indicated particularly in cases where renal metastatic disease is suspected and active surveillance or ablative treatment is planned. [10] Renal biopsy allows discrimination of benign masses that do not require treatment from progressive diseases. Performing renal biopsy before treatment has become more common due to its high sensitivity (97.5-99.7%) and specificity (96.2-99.1%) of histopathological examination.…”

mentioning

confidence: 99%

“…Despite the reported risks of this procedure such as hematoma, gross hematuria, retroperitoneal hemorrhage, pneumothorax, and seeding of tumor cells, these complications are not as high as have been anticipated. [10] A coaxial technique allowing multiple biopsies through a coaxial cannula should always be used to avoid potential tumour seeding. [14] The ability of renal biopsy to provide an accurate diagnosis with low morbidity and high incidence has led researchers to underline the importance of performing this procedure on all patients before planning treatment for SRMs.…”

mentioning

confidence: 99%

“…[15][16][17][18] Important factors preventing establishment of diagnosis based on renal biopsy are the cystic nature and poor contrast enhancement of renal masses and the distance (average 13 cm) between the skin and the renal mass. [10] Furthermore, poorly differentiated tumors may include areas of necrosis and bleeding [11] , which makes it difficult to make an accurate diagnosis with renal biopsy.…”

mentioning

confidence: 99%

“…[43] Every 1 cm increase in the size of renal tumor results in a 47% reduction in the rate of performing PN. [10] In addition, high comorbidity, female gender, and surgeons' belief that PN has higher complication rate may be considered as reasons for PN being a less favorable option. However, many factors such as the patient's educational, sociocultural and income levels and health insurance status can play a role in the selection of treatment.…”

mentioning

confidence: 99%

See 4 more Smart Citations

Treatment approaches to small renal masses in patients of advanced age (≥75 years)

Ozcan

Altinova

Atan

2018

Turkish Journal of Urology

View full text Add to dashboard Cite

Cite this article as: Özcan MF, Altınova S, Atan A. Treatment approaches to small renal masses in patients of advanced age (≥75 years). Turk J Urol 2018; 44: 281-6. ABSTRACTThe elderly population is increasing in Turkey and across the world. With the frequent use of imaging modalities, the detection rate of coincidental small renal mass has also increased. Since small renal masses are generally not malignant, most of them can be followed up by active surveillance. In the current study, we examined the treatment options that can be offered to elderly patients with small renal masses. The optimum treatment method for patients of advanced age presenting with renal masses should be determined based on the presence of comorbidities such as age, renal function, and tumor characteristics.

show abstract

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Treatment approaches to small renal masses in patients of advanced age (≥75 years)

Ozcan

Altinova

Atan

2018

Turkish Journal of Urology

View full text Add to dashboard Cite

show abstract

Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma

Morris

Baerlocher

Dariushnia

et al. 2020

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

BACKGROUND It is estimated that, in 2019, 73,820 new cases of kidney cancer will be diagnosed in the United States, resulting in 14,770 new deaths (1). Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for approximately 9 out of 10 kidney cancers (2). Owing to the increasing use of cross-sectional imaging and improving life expectancies, the incidence rates of RCC have substantially increased in developed countries over the past 20 years (3). More than 50% of RCCs are detected incidentally on noninvasive imaging (4). Most of these incidentally detected masses are small and localized within the renal capsule. These small renal masses, measuring <4cm (stage T1a), account for 48%-66% of all RCCs (5). In contrast, metastatic RCC accounts for about 17% of all RCCs at diagnosis (6). For small (4 cm in diameter) renal tumors, treatment options have traditionally included active surveillance, radical nephrectomy (RN), and nephron-sparing partial nephrectomy (PN). Nephron-sparing therapies have become popular to preserve renal function, particularly since oncologic outcomes from PN are equal to those from RN, thus making PN widely accepted as the standard of care for the management of clinically localized RCC (7-12). However, many patients are not candidates for surgery. For these patients, percutaneous image-guided ablation (radiofrequency [RF] ablation), cryoablation, and microwave (MW) ablation are available as validated options for tumor control. These have been established as important management options and are recommended by multiple societal guidelines (Appendix A [available online on the article's Supplemental Material page at www.jvir.org]), both nationally and internationally. In this document, the Society of Interventional Radiology (SIR) states its position on the use of ablation for the management of RCC, with a focus on small renal masses, biopsy, and cases of oligometastatic disease. An Executive Summary of recommendations in this document may be found in Appendix B

show abstract

Evaluation of Asymptomatic Microscopic Hematuria by Renal Ultrasound to Detect Upper Tract Malignancy: A 20-Year Experience in a Community Hospital

Smith

Read

Stegman

et al. 2019

Urology

View full text Add to dashboard Cite

Current Trends in Renal Surgery and Observation for Small Renal Masses

Cited by 16 publications

References 58 publications

Treatment approaches to small renal masses in patients of advanced age (≥75 years)

Treatment approaches to small renal masses in patients of advanced age (≥75 years)

Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma

Evaluation of Asymptomatic Microscopic Hematuria by Renal Ultrasound to Detect Upper Tract Malignancy: A 20-Year Experience in a Community Hospital

Contact Info

Product

Resources

About